The prevalence and treatment patterns of diabetes in the Greek population based on real-world data from the nation-wide prescription database

Diabetes Research and Clinical Practice

Volumn 118, Issue , 2016, Pages 162-167

  Liatis, Stavros ^a   Dafoulas, George E ^a   Kani, Chara ^b   Politi, Anastasia ^b   Litsa, Panagiota ^b   Sfikakis, Petros P ^a   Makrilakis, Konstantinos ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b Oral Medicine Clinic National Organization for the Provision of Health Services (IKA)   (Greece)

Author keywords

Diabetes prevalence; Prescription database; Treatment patterns; Type 1 diabetes prevalence

Indexed keywords

DIPEPTIDYL PEPTIDASE IV INHIBITOR; INSULIN; METFORMIN; SULFONYLUREA DERIVATIVE; ANTIDIABETIC AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DATA BASE; FEMALE; GREECE; GREEK (CITIZEN); GROUPS BY AGE; HEALTH CARE POLICY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POPULATION RESEARCH; PRESCRIPTION; PREVALENCE; REIMBURSEMENT; SEX DIFFERENCE; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; INFANT; MIDDLE AGED; NEWBORN; PRESCHOOL CHILD; SEX RATIO; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIPEPTIDYL-PEPTIDASE IV INHIBITORS; DRUG PRESCRIPTIONS; FEMALE; GREECE; HUMANS; HYPOGLYCEMIC AGENTS; INFANT; INFANT, NEWBORN; INSULIN; MALE; METFORMIN; MIDDLE AGED; PREVALENCE; SEX DISTRIBUTION; SULFONYLUREA COMPOUNDS; YOUNG ADULT;

EID: 84976594516     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2016.06.018     Document Type: Article

References (36)

1. [1] WHO Global Infobase, < https://apps.who.int/infobase/Indicators.aspx>; [accessed 09.01.2016].
2. [2] Ismail, A.A., Beeching, N.J., Gill, G.V., Bellis, M.A., How many data sources are needed to determine diabetes prevalence by capture-recapture?. Int J Epidemiol 29 (2000), 536–541.
3. [3] Morton, L.M., Cahill, J., Hartge, P., Reporting participation in epidemiologic studies: a survey of practice. Am J Epidemiol 163 (2006), 197–203.
4. [4] < www.eopyy.gov.gr>.
5. [5] Strøm, H., Selmer, R., Birkeland, K.I., Schirmer, H., Berg, T.J., Jenum, A.K., et al. No increase in new users of blood glucose-lowering drugs in Norway 2006–2011: a nationwide prescription database study. BMC Public Health, 14, 2014, 520.
6. [6] Berg, Christian, Strøm, Hanne, Norwegian Prescription Database (NorPD) as a data source for diabetes research. Nor Epidemiologi 23 (2013), 109–110.
7. [7] Katsilambros, N., Aliferis, K., Darviri, C., Tsapogas, P., Alexiou, Z., Tritos, N., et al. Evidence for an increase in the prevalence of known diabetes in a sample of an urban population in Greece. Diabet Med 10 (1993), 87–90.
8. [8] Papazoglou, N., Manes, C., Chatzimitrofanous, P., Papadeli, E., Tzounas, K., Scaragas, G., et al. Epidemiology of diabetes mellitus in the elderly in northern Greece: a population study. Diabet Med 12 (1995), 397–400.
9. [9] Lionis, C.D., Sasarolis, S.M., Koutis, A.D., Antonakis, N.A., Benos, A., Papavasiliou, S., et al. Measuring the prevalence of diabetes mellitus in a Greek primary health care district. Fam Pract 13 (1996), 18–21.
10. [10] Panagiotakos, D.B., Pitsavos, C., Chrysohoou, C., Stefanadis, C., The epidemiology of Type 2 diabetes mellitus in Greek adults: the ATTICA study. Diabet Med 22 (2005), 1581–1588.
11. [11] Melidonis, A.M., Tournis, S.M., Kompoti, M.K., Lentzas, I.L., Roussou, V.R., Iraklianou, S.L., et al. Increased prevalence of diabetes mellitus in a rural Greek population. Rural Remote Health, 6, 2006, 534.
12. [12] Gikas, A., Sotiropoulos, A., Panagiotakos, D., Pastromas, V., Paraskevopoulou, E., Skliros, E., et al. Rising prevalence of diabetes among Greek adults: findings from two consecutive surveys in the same target population. Diabetes Res Clin Pract 79 (2008), 325–329.
13. [13] Tentolouris, N., Andrianakos, A., Karanikolas, G., Karamitsos, D., Trontzas, P., Krachtis, P., et al. Prevalence of diabetes mellitus and obesity in the general adult population of Greece: a door-to-door epidemiological study. Diabet Med 26 (2009), 451–452.
14. [14] Greek Government Gazette 1753 B, issued on 28 June 2014.
15. [15] Greek Government Gazette 1747 B, issued on 30th November 2006.
16. [16] < http://www.statistics.gr/en/2011-census-pop-hous>; last [accessed 09.01.2016].
17. [17] Spasoff, R.A., Epidemiologic methods for health policy. 1999, Oxford University Press, Inc., New York.
18. [18] Garrison, L.P., Neumann, P.J., Erickson, P., Marshall, D., Mullins, C.D., ISPOR using real-world data for coverage and payment decisions: the ISPOR Real-World Data Task Force report. Value Health 10 (2007), 326–335.
19. [19] Whiting, D.R., Guariguata, L., Weil, C., Shaw, J., IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 94 (2011), 311–321.
20. [20] Soriguer, F., Goday, A., Bosch-Comas, A., Bordiú, E., Calle-Pascual, A., Carmena, R., et al. Prevalence of diabetes mellitus and impaired glucose regulation in Spain: the Di@bet.es Study. Diabetologia 55 (2012), 88–93.
21. [21] Patsopoulou, A., Tsimtsiou, Z., Katsioulis, A., Rachiotis, G., Malissiova, E., Hadjichristodoulou, C., Prevalence and risk factors of overweight and obesity among adolescents and their parents in Central Greece (FETA Project). Int J Environ Res Public Health, 13, 2015, E83 pii.
22. [22] Hassapidou, M., Daskalou, E., Tsofliou, F., Tziomalos, K., Paschaleri, A., Pagkalos, I., Tzotzas, T., Prevalence of overweight and obesity in preschool children in Thessaloniki, Greece. Hormones (Athens) 14 (2015), 615–622.
23. [23] Kentikelenis, A., Karanikolos, M., Papanicolas, I., Basu, S., McKee, M., Stuckler, D., Health effects of financial crisis: omens of a Greek tragedy. Lancet 378 (2011), 1457–1458.
24. [24] Gale, E.A., Gillespie, K.M., Diabetes and gender. Diabetologia 44 (2001), 3–15.
25. [25] Wändell, P.E., Carlsson, A.C., Time trends and gender differences in incidence and prevalence of type 1 diabetes in Sweden. Curr Diabetes Rev 9 (2013), 342–349.
26. [26] Green, A., Patterson, C.C., EURODIAB TIGER Study Group. Europe and Diabetes. Trends in the incidence of childhood-onset diabetes in Europe 1989–1998. Diabetologia 4:Suppl. 3 (2001), B3–B8.
27. [27] < www.ede.gr> (Hellenic Diabetes Association website).
28. [28] Inzucchi, S.E., Bergenstal, R.M., Buse, J.B., Diamant, M., Ferrannini, E., Nauck, M., et al. Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 38 (2015), 140–149.
29. [29] Alexander, G.C., Sehgal, N.L., Moloney, R.M., Stafford, R.S., National trends in treatment of type 2 diabetes mellitus, 1994–2007. Arch Intern Med 168 (2008), 2088–2094.
30. [30] Phung, O.J., Scholle, J.M., Talwar, M., Coleman, C.I., Effect of noninsulin antidiabetic drugs added to metformin therapy on glycemic control, weight gain, and hypoglycemia in type 2 diabetes. JAMA 303 (2010), 1410–1418.
31. [31] Liatis, S., Papaoikonomou, S., Ganotopoulou, A., Papazafiropoulou, A., Dinos, C., Michail, M., Xilomenos, A., Melidonis, A., Pappas, S., et al. Management of type 2 diabetes and its prescription drug cost before and during the economic crisis in Greece: an observational study. BMC Endocr Disord 5 (2014), 14–23.
32. [32] Sinha, A., Rajan, M., Hoerger, T., Pogach, L., Costs and consequences associated with newer medications for glycemic control in type 2 diabetes. Diabetes Care 33 (2010), 695–700.
33. [33] Zhang, Y., McCoy, R.G., Mason, J.E., Smith, S.A., Shah, N.D., Denton, B.T., Second-line agents for glycemic control for type 2 diabetes: are newer agents better?. Diabetes Care 37 (2014), 1338–1345.
34. [34] World Health Organization, Access to new medicines in Europe: technical review of policy initiatives and opportunities for collaboration and research. 2015.
35. [35] Cowie, C.C., Rust, K.F., Ford, E.S., et al. Full accounting of diabetes and pre-diabetes in the U.S. population in 1988–1994 and 2005–2006. Diabetes Care 32 (2009), 287–294.
36. [36] Heidemann, C., Du, Y., Paprott, R., Haftenberger, M., Rathmann, W., Scheidt-Nave, C., Temporal changes in the prevalence of diagnosed diabetes, undiagnosed diabetes and prediabetes: findings from the German Health Interview and Examination Surveys in 1997–1999 and 2008–2011. Diabet Med, 2015 Oct 26. [Epub ahead of print].